サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1499982

バイオインフォマティクスの世界市場の評価：製品別、用途別、部門別、地域別、機会、予測（2017年～2031年）

Bioinformatics Market Assessment, By Product, By Application, By Sector, By Region, Opportunities and Forecast, 2017-2031F

出版日
ページ情報
英文 223 Pages
納期
3～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.63円
バイオインフォマティクスの世界市場の評価：製品別、用途別、部門別、地域別、機会、予測（2017年～2031年）
出版日: 2024年06月25日
発行: Markets & Data
ページ情報: 英文 223 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバイオインフォマティクスの市場規模は、2023年の126億5,000万米ドルから2031年に303億3,000万米ドルに達すると予測され、予測期間の2024年～2031年にCAGRで11.55%の成長が見込まれます。投資の拡大、技術の進歩、バイオインフォマティクスプラットフォームに対する高い需要、広範なゲノム解析の利用、産業パートナーシップの増加などのさまざまな要因が世界のバイオインフォマティクス市場を形成しています。市場は研究投資の増加により大きく成長しつつあり、この動向は予測期間にも続く見込みです。民間および公共の機関によるこうした投資の結果、バイオインフォマティクスの利用が増加し、産業における革新的なソリューションが開発されます。AI、クラウドコンピューティング、機械学習などの先進技術が世界のバイオインフォマティクス市場を拡大しています。新しいバイオインフォマティクスツールやプラットフォームの開発により、データの迅速かつ正確な分析が可能になっています。

バイオインフォマティクスプラットフォームに対する需要は根強く、大量の遺伝子データを解析できることから、世界のバイオインフォマティクス市場の拡大を後押しすると予測されます。バイオインフォマティクスのアルゴリズムやツールは、研究者がデータ内のパターンや関係を簡単に見つけることができるため、ゲノム解析に好まれます。これらのツールは、ゲノム解析から得られる大量のデータを容易に処理でき、エラーの可能性を減らすことで信頼性を高めることができます。

北米は現在、豊富な資源、革新的ソリューションの研究開発への多額の投資、確立されたインフラにより、世界のバイオインフォマティクス市場を独占しています。バイオテクノロジー産業の大手企業は米国とカナダに拠点を置いており、バイオインフォマティクス部門のハブとなっています。

例えば、精密医療を世界的に推進する最先端のソリューションを提供するため、医療部門のクラウドネイティブソフトウェア企業でデータ駆動型医療のリーダーであるSOPHiA GENETICSは、2024年4月にバイオインフォマティクスと診断学のパイオニアであるStrand Life Sciencesとの戦略的提携を発表しました。OPHiA GENETICSは、そのキュレートされたバリアントデータベースとバイオインフォマティクスソリューションの専門知識を通じて、分散型SOPHiA DDM Platformを通じてStrandをサポートします。両社は、戦略的な検査の共同開発や、インドと世界における健康転帰を向上させるためのその他の取り組みにおいて協力します。

バイオインフォマティクスへの投資の拡大が世界のバイオインフォマティクス市場を後押し

バイオテクノロジーの主要企業は、バイオインフォマティクス部門に資金を投入しています。このような投資を通じて、企業は新しい市場や地域に進出しながら、新しい技術や優れた知見を提供することができます。大規模な支出は、技術革新を推進し、世界のバイオインフォマティクス部門を拡大することへの献身を示すことができます。バイオインフォマティクスへの投資は、バイオテクノロジー企業の地位をさらに強固なものにし、複雑なゲノムデータから価値ある知見を引き出したいと考えている人々の間で顧客基盤を拡大します。例えば、エピジェネティックバイオマーカー技術の商業化で業界をリードするFOXO Technologies Inc.は、2023年7月にバイオインフォマティクスサービスを開始すると発表しました。同社は、このプラットフォームが生物学、バイオテクノロジー、医療のブレークスルーを加速し、拡大するエピジェネティクスの研究分野に革命をもたらすことを期待しています。FOXOは、最先端のバイオインフォマティクスツールを提供することで、顧客がデータセットをより迅速かつ正確に処理、分析、解釈し、発見をより迅速に行い、複雑な疾患をより深く理解できるよう支援することを目指しています。

当レポートでは、世界のバイオインフォマティクス市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界のバイオインフォマティクス市場の見通し（2017年～2031年）

  • 市場規模と予測
    • 金額
  • 製品別
    • ナレッジマネジメントツール
    • バイオインフォマティクスサービス
    • バイオインフォマティクスプラットフォーム
  • 用途別
    • DNAシーケンス
    • ゲノム解析
    • 進化生物学
    • イムノインフォマティクス
    • 精密医療
    • 遺伝子発現
    • プロテオミクス
    • その他
  • 部門別
    • 医療バイオテクノロジー
    • 動物バイオテクノロジー
    • 植物バイオテクノロジー
    • 環境バイオテクノロジー
    • 法医学バイオテクノロジー
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 南米
    • 中東・アフリカ
  • 市場シェア：企業別（2023年）

第5章 世界のバイオインフォマティクス市場の見通し：地域別（2017年～2031年）

  • 北米
    • 市場規模と予測
    • 製品別
    • 用途別
    • 部門別
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • 英国
    • ロシア
    • オランダ
    • スペイン
    • トルコ
    • ポーランド
  • アジア太平洋
    • インド
    • 中国
    • 日本
    • オーストラリア
    • ベトナム
    • 韓国
    • インドネシア
    • フィリピン
  • 南米
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ

第6章 市場マッピング（2023年）

  • 製品別
  • 用途別
  • 部門別
  • 地域別

第7章 マクロ環境と産業構造

  • 需給分析
  • バリューチェーン分析
  • PESTEL分析
  • ポーターのファイブフォース分析

第8章 市場力学

  • 成長促進要因
  • 成長抑制要因（課題、抑制要因）

第9章 規制枠組みとイノベーション

  • 特許情勢
  • イノベーション/新技術

第10章 主要企業の情勢

  • マーケットリーダー上位5社の競合マトリクス
  • マーケットリーダー上位5社の市場収益の分析（2023年）
  • 合併と買収/合弁事業（該当する場合）
  • SWOT分析（市場企業5社）
  • 特許分析（該当する場合）

第11章 ケーススタディ

第12章 主要企業の見通し

  • Thermo Fisher, Inc.
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Waters Corporation
  • NeoGenomics Laboratories, Inc.
  • Revvity, Inc.
  • Quest Diagnostics Incorporated
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific SE

第13章 戦略的推奨

第14章 当社について、免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 3. Global Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 4. Global Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 5. Global Bioinformatics Market Share (%), By Region, 2017-2031F
  • Figure 6. North America Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 7. North America Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 8. North America Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 9. North America Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 10. North America Bioinformatics Market Share (%), By Country, 2017-2031F
  • Figure 11. United States Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 12. United States Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 13. United States Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 14. United States Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 15. Canada Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. Canada Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 17. Canada Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 18. Canada Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 19. Mexico Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 20. Mexico Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 21. Mexico Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 22. Mexico Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 23. Europe Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 24. Europe Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 25. Europe Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 26. Europe Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 27. Europe Bioinformatics Market Share (%), By Country, 2017-2031F
  • Figure 28. Germany Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 29. Germany Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 30. Germany Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 31. Germany Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 32. France Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 33. France Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 34. France Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 35. France Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 36. Italy Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 37. Italy Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 38. Italy Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 39. Italy Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 40. United Kingdom Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. United Kingdom Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 42. United Kingdom Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 43. United Kingdom Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 44. Russia Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 45. Russia Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 46. Russia Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 47. Russia Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 48. Netherlands Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 49. Netherlands Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 50. Netherlands Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 51. Netherlands Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 52. Spain Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Spain Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 54. Spain Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 55. Spain Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 56. Turkey Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 57. Turkey Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 58. Turkey Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 59. Turkey Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 60. Poland Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 61. Poland Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 62. Poland Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 63. Poland Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 64. South America Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. South America Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 66. South America Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 67. South America Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 68. South America Bioinformatics Market Share (%), By Country, 2017-2031F
  • Figure 69. Brazil Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 70. Brazil Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 71. Brazil Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 72. Brazil Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 73. Argentina Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 74. Argentina Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 75. Argentina Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 76. Argentina Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 77. Asia-Pacific Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 78. Asia-Pacific Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 79. Asia-Pacific Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 80. Asia-Pacific Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 81. Asia-Pacific Bioinformatics Market Share (%), By Country, 2017-2031F
  • Figure 82. India Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. India Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 84. India Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 85. India Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 86. China Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 87. China Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 88. China Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 89. China Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 90. Japan Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 91. Japan Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 92. Japan Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 93. Japan Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 94. Australia Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. Australia Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 96. Australia Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 97. Australia Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 98. Vietnam Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 99. Vietnam Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 100. Vietnam Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 101. Vietnam Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 102. South Korea Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 103. South Korea Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 104. South Korea Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 105. South Korea Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 106. Indonesia Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 107. Indonesia Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 108. Indonesia Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 109. Indonesia Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 110. Philippines Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 111. Philippines Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 112. Philippines Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 113. Philippines Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 114. Middle East & Africa Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 115. Middle East & Africa Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 116. Middle East & Africa Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 117. Middle East & Africa Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 118. Middle East & Africa Bioinformatics Market Share (%), By Country, 2017-2031F
  • Figure 119. Saudi Arabia Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 120. Saudi Arabia Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 121. Saudi Arabia Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 122. Saudi Arabia Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 123. UAE Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 124. UAE Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 125. UAE Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 126. UAE Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 127. South Africa Bioinformatics Market, By Value, In USD Billion, 2017-2031F
  • Figure 128. South Africa Bioinformatics Market Share (%), By Product, 2017-2031F
  • Figure 129. South Africa Bioinformatics Market Share (%), By Application, 2017-2031F
  • Figure 130. South Africa Bioinformatics Market Share (%), By Sector, 2017-2031F
  • Figure 131. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 132. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 133. By Sector Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 134. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
目次
Product Code: MX11520

The global bioinformatics market is projected to witness a CAGR of 11.55% during the forecast period 2024-2031F, growing from USD 12.65 billion in 2023 to USD 30.33 billion in 2031F. Various factors are shaping the global bioinformatics market, such as growing investments, technological advancements, high demand for bioinformatics platforms, extensive genome analysis use, and increased industry partnerships. The global bioinformatics market is undergoing major growth because of the rise in research investments, which is expected to persist in the forecast period. As a result of these investments made by private and public institutions, there will be a rise in the use of bioinformatics and the development of innovative solutions in the industry. Advanced technologies like artificial intelligence, cloud computing, and machine learning are expanding the global bioinformatics market. Technologies have made it possible to analyze data quickly and accurately through the development of new bioinformatics tools and platforms.

There is expected to be a persistent demand for bioinformatics platforms, which will propel the expansion of the global bioinformatics market because of their ability to analyze large volumes of genetic data. Bioinformatics algorithms and tools are preferred for genome analysis as they enable researchers to easily find patterns and relationships within data. These tools can easily process a large amount of data obtained from genome analysis and increase reliability by decreasing the chances of error.

The North American region is currently dominating the global bioinformatics market due to abundant resources, significant investments in research and development of innovative solutions, and well-established infrastructure. Major players in the biotechnology industry are situated in the United States and Canada, making them hubs for the bioinformatics sector.

For example, to deliver cutting-edge solutions that will propel the use of precision medicine globally, SOPHiA GENETICS, a cloud-native software company in the healthcare space and a leader in data-driven medicine, announced a strategic partnership with Strand Life Sciences, a pioneer in bioinformatics and diagnostics, in April 2024. OPHiA GENETICS will support Strand through the decentralized SOPHiA DDM Platform through its curated variant databases and expertise in bioinformatics solutions. The companies will work together on strategic test co-development and other initiatives to enhance health outcomes in India and worldwide.

Growing Investments in Bioinformatics to Bolster the Global Bioinformatics Market

Major players in biotechnology are directing the funds into the bioinformatics sector as it would benefit the companies in numerous ways. Through these investments, the business can offer new technologies and improved insights while branching into new markets and geographical areas. Large-scale expenditures can show their dedication to driving innovation and expanding the global bioinformatics sector. Investing in bioinformatics will further solidify the position of biotech companies and expand their customer base among those looking to extract valuable insights from complex genomic data. For example, FOXO Technologies Inc., a leading company in the commercialization of epigenetic biomarker technology, announced the launch of its Bioinformatics Services in July 2023. The company hopes this platform will accelerate biological, biotechnological, and healthcare breakthroughs and revolutionize the expanding epigenetic research field. By providing a cutting-edge set of bioinformatic tools, FOXO aims to help its clients process, analyze, and interpret data sets more quickly and accurately, make discoveries more quickly, and better understand complicated diseases.

Technological Advancements to Drive the Global Bioinformatics Market

Technological advancements such as artificial intelligence, machine learning, and cloud computing drive the global bioinformatics market. The companies are adding more artificial intelligence (AI) and natural language processing (NLP) based technologies to analyze the insights and make informed decisions. Companies are also developing a new secondary analysis solution that is compliant with regulations for quick next-generation sequencing (NGS) analysis in clinical labs. As AI and human curation progress, companies like Qiagen Digital Insights provide dependable, superior molecular intelligence to support and expedite decision-making. Scalability, quick response times, and automated workflows are all provided by Qiagen Digital Insights. It also provides solutions that can be customized to match any database, API, service, or workflow application.

For example, Cyrus Biotechnology spun out Levitate Bio and Rosetta service provider on June 11, 2024, to provide automated, tailored AI solutions for biopharmaceutical drug discovery. The RosettaCommons Foundation will have a for-profit subsidiary called Levitate. For biopharma companies, Levitate offers advanced active pharmaceutical ingredients (API) tools, custom IT solutions, and graphical user interface (GUI) software that was built at Cyrus, where the platform produced dozens of biologics that were ready for the investigational new drug application (IND).

High Demand for Bioinformatics Platforms to Drive Market Growth

To offer their clients premium, personalized bioinformatics services, healthcare organizations are adopting bioinformatics platforms. Companies are creating software that allows scientists and medical professionals to evaluate and comprehend vast volumes of genetic data. By mapping a patient's complete genome rather than just one DNA panel, the bioinformatics platform analyses enormous quantities of patient data that may be used for more precise diagnosis and focused, efficient therapy. The platforms facilitate the implementation of genome sequencing for physicians and patients, offering fast access to information that can provide timely therapy modifications and an increased likelihood of a favorable outcome. For instance, launching its latest innovation at Biomarkers UK in February 2024, Metabolon, Inc. is a global leader in providing metabolomics solutions that advance a wide range of life science research, diagnostic, therapeutic development, and precision medicine applications.

Extensive Use in Genome Analysis to Propel the Bioinformatics Market

Bioinformatics is extensively used for genome analysis, propelling the growth of the global bioinformatics market. Bioinformatics is used throughout the whole process of creating genome-based cancer therapeutics. For instance, bioinformatics is used to evaluate the sequence and any associated molecular data to identify the precise genetic changes within the sample genome during the initial stages of gene variation detection. The statistical analysis of Single Nucleotide Polymorphism (SNP) data and the identification of hallmark SNPs for a particular haplotype block are actively influenced by bioinformatics. Dynamic programming is a bioinformatic method used to find the optical alignment of genetic sequences.

For instance, SOPHiA GENETICS, a global leader in data-driven medicine and a cloud-native healthcare technology company, announced in May 2024 that it is working with Microsoft Corporation and NVIDIA Corporation to combine their technological and genomics expertise to provide healthcare institutions with a streamlined and scalable whole genome sequencing (WGS) analytical solution.

North America Dominating the Bioinformatics Market

North America accounts for a significant share of the bioinformatics market due to the region's strong research and development, numerous advanced bioinformatics tools, and various technology-based companies, such as Oracle and Microsoft, and many others. The National Institutes of Health (NIH) and the National Science Foundation (NSF), two of North America's best scientific institutions and organizations, are major funders of bioinformatics research and development. There is increased demand for bioinformatics in North America because of the increasing number of chronic patients. In the United States, there were 609,820 cancer-related fatalities and 1,958,310 new cases of cancer in 2023. According to the Canadian Cancer Statistics, 45% of men and 43% of women in Canada will have cancer at some point in their lives. The aging and growing Canadian population is contributing to a steady increase in the number of new cancer cases.

For example, Next Gen Diagnostics announced on June 11th, 2024, that it will open its first laboratory in Cambridge, Massachusetts, offering partners and clients in the United States fully integrated, affordable bacterial sequencing and bioinformatics services. Next Gen Diagnostics provides sequencing along with comprehensive bioinformatics data at the lowest cost in the United States by utilizing the benefits of its automated pathogen bioinformatics systems and high throughput microfluidic sequencing sample preparation technology, NGD100.

Future Market Scenario (2024-2031F)

Bioinformatics is increasingly being used in the forensic industry, which will drive the growth of the global bioinformatics market in the coming years.

The increasing use of bioinformatics for synthetic biology will aid in creating new biological pathways, driving the growth of the global bioinformatics market.

Analysis of large amounts of data is becoming easier with bioinformatics.

Bioinformatics is extensively used to develop personalized treatment approaches for patients, which will increase demand in the global bioinformatics market.

Key Players Landscape and Outlook

Companies in the global bioinformatics market are forming collaborations to leverage collective expertise to assist partner organizations worldwide in implementing next-generation precision medicine to enhance patient care. Collaboration between two businesses enables them to leverage their bioinformatics knowledge to increase the capacity for precise analysis of important healthcare data and to promote the application of data-driven decision-making worldwide. The partnership uses both businesses' strong positions in the industry to give people access to cutting-edge bioinformatics services, advanced genomics technologies, and creative diagnostic solutions.

For example, through its wholly owned subsidiary MGRC Therapeutics Sdn Bhd ("MGRCT"), Malaysian Genomics Resource Centre Berhad (MGRC) and Twistcode Technologies Sdn Bhd (Twistcode) signed a memorandum of understanding (MoU) in May 2024 to concentrate on the Bioinformatics Enhanced-Accelerated Services Terminal (B.E.A.S.T.), a state-of-the-art platform that aims to transform bioinformatics services throughout Malaysia and the Middle East.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Bioinformatics Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. By Product
    • 4.2.1. Knowledge Management Tools
    • 4.2.2. Bioinformatics Services
    • 4.2.3. Bioinformatics Platforms
  • 4.3. By Application
    • 4.3.1. DNA Sequences
    • 4.3.2. Genome Analysis
    • 4.3.3. Evolutionary Biology
    • 4.3.4. Immunoinformatics
    • 4.3.5. Precision Medicine
    • 4.3.6. Gene Expression
    • 4.3.7. Proteomics
    • 4.3.8. Others
  • 4.4. By Sector
    • 4.4.1. Medical Biotechnology
    • 4.4.2. Animal Biotechnology
    • 4.4.3. Plant Biotechnology
    • 4.4.4. Environmental Biotechnology
    • 4.4.5. Forensic Biotechnology
    • 4.4.6. Others
  • 4.5. By Region
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia-Pacific
    • 4.5.4. South America
    • 4.5.5. Middle East and Africa
  • 4.6. By Company Market Share (%), 2023

5. Global Bioinformatics Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
    • 5.1.2. By Product
      • 5.1.2.1. Knowledge Management Tools
      • 5.1.2.2. Bioinformatics Services
      • 5.1.2.3. Bioinformatics Platforms
    • 5.1.3. By Application
      • 5.1.3.1. DNA Sequences
      • 5.1.3.2. Genome Analysis
      • 5.1.3.3. Evolutionary Biology
      • 5.1.3.4. Immunoinformatics
      • 5.1.3.5. Precision Medicine
      • 5.1.3.6. Gene Expression
      • 5.1.3.7. Proteomics
      • 5.1.3.8. Others
    • 5.1.4. By Sector
      • 5.1.4.1. Medical Biotechnology
      • 5.1.4.2. Animal Biotechnology
      • 5.1.4.3. Plant Biotechnology
      • 5.1.4.4. Environmental Biotechnology
      • 5.1.4.5. Forensic Biotechnology
      • 5.1.4.6. Others
    • 5.1.5. United States*
      • 5.1.5.1. Market Size & Forecast
        • 5.1.5.1.1. By Value
      • 5.1.5.2. By Product
        • 5.1.5.2.1. Knowledge Management Tools
        • 5.1.5.2.2. Bioinformatics Services
        • 5.1.5.2.3. Bioinformatics Platforms
      • 5.1.5.3. By Application
        • 5.1.5.3.1. DNA Sequences
        • 5.1.5.3.2. Genome Analysis
        • 5.1.5.3.3. Evolutionary Biology
        • 5.1.5.3.4. Immunoinformatics
        • 5.1.5.3.5. Precision Medicine
        • 5.1.5.3.6. Gene Expression
        • 5.1.5.3.7. Proteomics
        • 5.1.5.3.8. Others
      • 5.1.5.4. By Sector
        • 5.1.5.4.1. Medical Biotechnology
        • 5.1.5.4.2. Animal Biotechnology
        • 5.1.5.4.3. Plant Biotechnology
        • 5.1.5.4.4. Environmental Biotechnology
        • 5.1.5.4.5. Forensic Biotechnology
        • 5.1.5.4.6. Others
    • 5.1.6. Canada
    • 5.1.7. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East and Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Product
  • 6.2. By Application
  • 6.3. By Sector
  • 6.4. By Region

7. Macro Environment and Industry Structure

  • 7.1. Demand Supply Analysis
  • 7.2. Value Chain Analysis
  • 7.3. PESTEL Analysis
    • 7.3.1. Political Factors
    • 7.3.2. Economic System
    • 7.3.3. Social Implications
    • 7.3.4. Technological Advancements
    • 7.3.5. Environmental Impacts
    • 7.3.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.4. Porter's Five Forces Analysis
    • 7.4.1. Supplier Power
    • 7.4.2. Buyer Power
    • 7.4.3. Substitution Threat
    • 7.4.4. Threat From New Entrant
    • 7.4.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Patent Landscape
  • 9.2. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Case Studies

12. Key Players Outlook

  • 12.1. Thermo Fisher, Inc.
    • 12.1.1. Company Details
    • 12.1.2. Key Management Personnel
    • 12.1.3. Products and Services
    • 12.1.4. Financials (As Reported)
    • 12.1.5. Key Market Focus and Geographical Presence
    • 12.1.6. Recent Developments
  • 12.2. Qiagen N.V.
  • 12.3. Agilent Technologies, Inc.
  • 12.4. Illumina, Inc.
  • 12.5. Waters Corporation
  • 12.6. NeoGenomics Laboratories, Inc.,
  • 12.7. Revvity, Inc.
  • 12.8. Quest Diagnostics Incorporated
  • 12.9. Bio-Rad Laboratories, Inc.
  • 12.10. Eurofins Scientific SE

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

13. Strategic Recommendations

14. About Us & Disclaimer